The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the VENUS study: Bevacizumab efficacy and safety in platinum-sensitive recurrent ovarian cancer (OC)—A real-life ambispective study.
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Abbvie; Amgen; Genmab; Pfizer
Travel, Accommodations, Expenses - Roche
 
Jerome Alexandre
No Relationships to Disclose
 
Francois Goldwasser
No Relationships to Disclose
 
Jean-Philippe Spano
No Relationships to Disclose
 
Dominique Berton-Rigaud
No Relationships to Disclose
 
Aude-Marie Savoye
No Relationships to Disclose
 
Michel Fabbro
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Fernando Bazan
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Elsa Kalbacher
Consulting or Advisory Role - AstraZeneca; Leo Pharma; Roche; Sanofi
 
Nadia Raban
No Relationships to Disclose
 
Claire Giraud
No Relationships to Disclose
 
Virginie Pottier
No Relationships to Disclose
 
Frédéric Selle
No Relationships to Disclose
 
Anne Patsouris
Travel, Accommodations, Expenses - Eisai; Pfizer; Roche
 
Claire Garnier-Tixidre
No Relationships to Disclose
 
Anne Mercier Blas
No Relationships to Disclose
 
Jocelyne Provencal
No Relationships to Disclose
 
Fabien Brocard
No Relationships to Disclose
 
Jessica Berdougo-Tritz
No Relationships to Disclose
 
Vincent Launay-Vacher
Honoraria - Amgen; Bayer; Merck; MSD Oncology; Pierre Fabre; Roche; Sandoz; Tesaro
Consulting or Advisory Role - Onxeo; Pierre Fabre; Tesaro
Research Funding - Bayer (Inst); Pierre Fabre (Inst); Roche (Inst)